Nivolumab plus ipilimumab as neoadjuvant treatment in primary advanced renal cell tumors: Cutting edges for cutting-edge surgery
Related Experiment Video
Updated: Dec 25, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Karlijn de Joode1, Jolanda I de Ruig-Spakman2, Sarwan S Baktawar2
1Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.
No abstract available in PubMed .
More Related Videos
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
Related Concept Videos
Tumor Immunotherapy
Kidney Transplant II: Surgical Procedure
Treatment Resistant Cancers
Kidney Transplant III: Nursing Management